1,8-Cineole, a terpene, characterized as a major constituent occurring in the essential oils of several aromatic plants. It is widely used in pharmaceutical industry, as a food additive and for culinary purposes. This study investigates the inhibitory effect of 1,8-cineole on transit time and diarrhea in animal models. Acute toxicity and lethality of 1-8-cineole was determined by Lork's guidelines. The antidiarrheal effect of 1,8-cineole was investigated by determining the intestinal transit and enterpooling in rats. In all experiments, different doses of 1,8-cineole (20-120 mg/kg), atropine, and loperamide were administered orally. The LD50 of 1,8-cineole for oral administration was estimated to be 1280 mg/kg. 1,8-Cineole (20-120 mg/kg) did not show a significant decrease in small intestine transit (p > 0.05); however, the highest dose displayed a significant decrease in comparison with atropine (p < 0.05). This substance decreased the peristaltic index value to 68 ± 0.36% at a dose of 120 mg/kg compared with the control group (85.22 ± 4.31%) in the castor oil transit test. 1,8-Cineole significantly delayed the onset of diarrhea to -142.33 ± 6.08 min at 120 mg/kg, while the time was 103.66 ± 20.73 min for the control and >240 min for the loperamide. Moreover, 1,8-cineole significantly decreased intestinal fluid accumulation (p < 0.05). This study demonstrated antispasmodic and antisecretory activities of 1,8-cineole and rationalized the traditional use of the plant containing various levels of this terpene in the treatment of gastrointestinal complains such as diarrhea.
Tarragon [Artemisia dracunculus L. (Asteraceae)] is used as a commercial flavoring and in perfumery. In traditional folk medicine, tarragon has been used for treatment of pain and gastrointestinal disturbances. This study investigated the antinociceptive effect of the essential oil of A. dracunculus (EOAD) in various experimental models. The median lethal dose (LD50) of EOAD was estimated using the method of Lorke. The antinociceptive effect was assessed using chemical (formalin and acetic acid) and thermal (hot-plate) nociceptive tests in rats and mice. In all experiments, EOAD was administered intraperitoneally at the doses of 10, 30, 100 and 300 mg/kg. In the acute toxicity test, the value of estimated LD50 for EOAD was 1250 mg/kg. EOAD (100 and 300 mg/kg) significantly reduced (p < 0.001) the pain response in the first (59.5 and 91.4%) and second (52.5 and 86.3%) phases of the formalin test, respectively. Central involvement in analgesic profile was confirmed by the hot-plate test, in which the EOAD showed a significant analgesic activity by increasing latency time. EOAD (10, 30, 100 and 300 mg/kg) significantly (p < 0.001) inhibited (89, 95, 97 and 97%) the nociception produced by acetic acid. Naloxone failed to antagonize the antinociceptive effect of the essential oil in the acetic acid-induced writhing test. It seems that mechanism(s) other than opioid receptors is (are) involved in the analgesic effect of EOAD. This study reported the peripheral and central antinociceptive activity of the EOAD and rationalized the traditional use of the plant in the treatment of different painful conditions.
Recent anxiety about resistance to chemical drugs has elevated the position of phytogenic feed additives including Nigella sativa in preventive strategy in the poultry industry. During this study, a completely randomized experiment was designed to investigate the efficacy of different levels (0 to 16%) of N. sativa seeds supplemented in the diet of broilers on performance, immune responses, and hematological and biochemical parameters. The results indicated the following: (a) Supplementation of 1% N. sativa seeds in diet had the highest positive effects and 16% N. sativa had the highest significant ( ) adverse effects on weight gain, while up to 2% N. sativa seeds in the diet reduced feed conversion ratio (FCR) whereas 4% and over that increased the FCR. (b) Chickens fed with a diet containing 1% N. sativa seeds had the highest antibody titers, but those fed with 16% N. sativa seeds had the lowest antibody titers at end of the experiment. (c) Dietary inclusion of N. sativa seeds increased hemogram parameters and the group fed with 16% N. sativa seeds had the highest values on day 21 until the end of the experiment. (d) Supplementation of N. sativa seeds decreased in WBC and lymphocytes but increased heterophils, H/L, monocytes, eosinophils, and basophils percentages. Supplementation of up to 2% of N. sativa seeds in broiler’s diets elaborated serum level of those parameters, while supplementation of ≥ 4% N. sativa seeds decreased their serum levels. In conclusion, supplementation of N. sativa seed (1-2%) in broiler diets, as a multipurpose natural growth promoter, improves performance, elevates humoral immune responses, affects serum biochemical profiles of broiler chickens, and induces changes in their hemogram and leukogram, while there are no side, residual, and hazardous effects.
22 December 2016 in Advanced Pharmaceutical Bulletin